Goldman Sachs’s Guardant Health GH Stock Holding History

Goldman Sachs’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10,000	Closed	-$538K	–	6100
2022 Q3	$538K	Buy	+10,000	New	+$513K	﹤0.01%	4919
2022 Q1	–	Sell	-4,200	Closed	-$420K	–	6683
2021 Q4	$420K	Hold	4,200	–	–	﹤0.01%	5482
2021 Q3	$525K	Buy	+4,200	New	+$499K	﹤0.01%	5164
2019 Q3	–	Sell	-10,400	Closed	-$898K	–	5239
2019 Q2	$898K	Hold	10,400	–	–	﹤0.01%	4061
2019 Q1	$798K	Buy	+10,400	New	+$577K	﹤0.01%	4182

Other funds holding GH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Goldman Sachs's GH Position: Q1 2026 in Review

Goldman Sachs increased its Guardant Health (GH) stake by 69% in Q1 2026, buying an estimated $182M and bringing the position to 4,435,839 shares worth $410M. The position accounts for 0.05% of the portfolio, ranked #402.

Goldman Sachs first reported a position in GH in Q4 2018 and has held it in 30 quarters since. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

Goldman Sachs held 4,435,839 shares of Guardant Health worth $410M as of Q1 2026.
Goldman Sachs bought 1,808,130 Guardant Health shares in Q1 2026, an estimated $182M.
Guardant Health made up 0.05% of Goldman Sachs's portfolio in Q1 2026, its #402 holding.
Goldman Sachs first reported a position in Guardant Health in Q4 2018 and has held it in 30 quarters since.
481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.